Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmelo Scarpignato

Showing results (11-20 of 125) with videos related to

Pageof 13
Sort By:
Digestion|February 25, 2006
Microbial flora in NSAID-induced intestinal damage: a role for antibiotics?Angel Lanas, Carmelo Scarpignato
Chemotherapy|April 28, 2005
Rifaximin, a peculiar rifamycin derivative: established and potential clinical use outside the gastrointestinal tractIva Pelosini, Carmelo Scarpignato
Current Gastroenterology Reports|November 14, 2019
Drug-Induced Small Bowel Injury: a Challenging and Often Forgotten Clinical ConditionCarmelo Scarpignato, Ingvar Bjarnason
American Journal of Surgery|April 12, 2002
Early esophageal transit study after laparoscopic fundoplication: how useful is it?Sandro Contini, Carmelo Scarpignato
European Journal of Gastroenterology & Hepatology|December 4, 2025
Potassium-competitive acid blockers versus proton pump inhibitors: redefining the standards of care in reflux esophagitisCarmelo Scarpignato, Luigi Gatta
Expert Review of Gastroenterology & Hepatology|November 26, 2009
Rifaximin in the management of colonic diverticular diseaseGiovanni Latella, Carmelo Scarpignato
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 1, 2020
Addressing long-term PPI safetyCarmelo Scarpignato, Salvatore Tolone
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 16, 2025
From erosive to non-erosive reflux disease: broadening the scope of P-CAB therapyCarmelo Scarpignato, Luigi Gatta
Therapeutic Advances in Gastroenterology|August 25, 2022
Pharmacologic treatment of GERD in adolescents: Is esophageal mucosal protection an option?Claudio Romano, Carmelo Scarpignato
Current Treatment Options in Gastroenterology|October 27, 2018
Potent Acid Suppression with PPIs and P-CABs: What's New?Richard H Hunt, Carmelo Scarpignato
Pageof 13

Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
Digestion|February 25, 2006
Microbial flora in NSAID-induced intestinal damage: a role for antibiotics?Angel Lanas, Carmelo Scarpignato
Chemotherapy|April 28, 2005
Rifaximin, a peculiar rifamycin derivative: established and potential clinical use outside the gastrointestinal tractIva Pelosini, Carmelo Scarpignato
Current Gastroenterology Reports|November 14, 2019
Drug-Induced Small Bowel Injury: a Challenging and Often Forgotten Clinical ConditionCarmelo Scarpignato, Ingvar Bjarnason
American Journal of Surgery|April 12, 2002
Early esophageal transit study after laparoscopic fundoplication: how useful is it?Sandro Contini, Carmelo Scarpignato
European Journal of Gastroenterology & Hepatology|December 4, 2025
Potassium-competitive acid blockers versus proton pump inhibitors: redefining the standards of care in reflux esophagitisCarmelo Scarpignato, Luigi Gatta
Expert Review of Gastroenterology & Hepatology|November 26, 2009
Rifaximin in the management of colonic diverticular diseaseGiovanni Latella, Carmelo Scarpignato
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 1, 2020
Addressing long-term PPI safetyCarmelo Scarpignato, Salvatore Tolone
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 16, 2025
From erosive to non-erosive reflux disease: broadening the scope of P-CAB therapyCarmelo Scarpignato, Luigi Gatta
Therapeutic Advances in Gastroenterology|August 25, 2022
Pharmacologic treatment of GERD in adolescents: Is esophageal mucosal protection an option?Claudio Romano, Carmelo Scarpignato
Current Treatment Options in Gastroenterology|October 27, 2018
Potent Acid Suppression with PPIs and P-CABs: What's New?Richard H Hunt, Carmelo Scarpignato
Pageof 13